US Physical Therapy Inc

US Physical Therapy Inc (USPH) Stock Analysis

$85.980

+1.083 (+1.26%)At close

Loading chart…
High
87.410
Open
85.910
VWAP
85.86
Volume
302.80K
Mkt Cap
1.40B
Low
84.180
Amount
26.00M
EV/EBITDA, TTM
13.20

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.

www.usph.com

AI analysis of US Physical Therapy Inc (USPH)

Buy

US Physical Therapy Inc is a good buy right now, with a current price of $84.67 and a strong RSI of 60.69, indicating bullish momentum. The company reported a revenue increase of 8.5% year-over-year in Q2 2026, reaching $214.06 million, which beat market expectations. However, the main risk is the earnings miss, with a reported EPS of $0.25, falling short of expectations by $0.53, which could affect investor confidence.

Analyst Ratings (7)

+18.05% upside
Hold
2 Buy
5 Hold
0 Sell
Current: 85.98
Low
100.00
Average
101.50
High
103.00

JPMorgan

2026-09-11

Price Target

$95

Overweight

Barrington

2026-08-10

Price Target

$98

Outperform

Barrington

2026-05-13

Price Target

$90

Outperform

Citizens

2026-05-08

Price Target

$98

Outperform

Jefferies

2026-03-09

Price Target

$102

Buy

Valuation Metrics

The current forward P/E ratio for US Physical Therapy Inc (USPH) is 27.25, compared to its 5-year average forward P/E of 32.92.

Forward P/E

Undervalued
5Y Average P/E
32.92
Current P/E
27.25
Overvalued
38.11
Undervalued
27.73

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
19.10
Current EV/EBITDA
13.20
Overvalued
22.50
Undervalued
15.71

Forward P/S

Undervalued
5Y Average P/S
1.94
Current P/S
1.40
Overvalued
2.39
Undervalued
1.49

Alphio AI Price Scenarios for USPH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%USPH

$100.54

Scenario price

B

Base

Base · 50%USPH

$97.38

Scenario price

B

Bear

Bear · 25%USPH

$95.30

Scenario price

Whales holding USPH

C

Copeland Capital Management, LLC

+ HoldingUSPH

-6.86%

3M Return

Events Timeline

2026-09-21 (ET)

08:00:00

U.S. Physical Therapy Appoints Myra Davis to Board of Directors

2026-08-05 (ET)

16:30:00

USPH Reports Q2 Revenue of $214.1M, Beating Expectations

16:30:00

U.S. Physical Therapy Confirms FY26 Adjusted EBITDA Outlook of $102M-$106M

2026-07-02 (ET)

08:00:00

U.S. Physical Therapy Acquires 12-Clinic Practice, Holds 67% Stake

2026-05-06 (ET)

16:30:00

USPH Reaffirms 2026 EBITDA Guidance of $102M to $106M

News

USPH FAQ — answered by Alphio AI

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

US Physical Therapy Inc is a good buy right now, with a current price of $84.67 and a strong RSI of 60.69, indicating bullish momentum. The company reported a revenue increase of 8.5% year-over-year in Q2 2026, reaching $214.06 million, which beat market expectations. However, the main risk is the earnings miss, with a reported EPS of $0.25, falling short of expectations by $0.53, which could affect investor confidence.

7 analysts cover USPH: 2 rate it Buy, 5 Hold and 0 Sell. The average price target is 101.50.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading